AJU IB Investment Co., Ltd. Long-Term Concentrated

Location: Seoul, Korea, Republic of

CIK: 0001710065 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 10, 2026

Total Value: $22.79M (100.0% shares, 0.0% debt)

Holdings (7)

ACLX ARCELLX INC 63.9%

Value $14.57M Shares 223,486 Est. Cost $16.72 Unrealized +377.1%

— RALLYBIO CORP 18.2%

Value $4.142M Shares 754,678 Est. Cost $9.54 Unrealized —

KYMR KYMERA THERAPEUTICS INC 6.7%

Value $1.529M Shares 19,648 Est. Cost $48.78 Unrealized +38.4%

SEER SEER INC 6.6%

Value $1.494M Shares 816,375 Est. Cost $63.62 Unrealized -96.8%

XLO XILIO THERAPEUTICS INC 1.9%

Value $427K Shares 667,742 Est. Cost $17.03 Unrealized -95.6%

— RAPT THERAPEUTICS INC 1.8%

Value $421K Shares 12,437 Est. Cost $19.75 Unrealized —

— SUTRO BIOPHARMA INC 0.9%

Value $202K Shares 17,500 Est. Cost $21.71 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACLX	ARCELLX INC	223,486	$14.57M	63.9%	$16.72	+377.1%	COMMON STOCK	03940C100
—	RALLYBIO CORP	754,678	$4.142M	18.2%	$9.54	—	COM	75120L100
KYMR	KYMERA THERAPEUTICS INC	19,648	$1.529M	6.7%	$48.78	+38.4%	COM	501575104
SEER	SEER INC	816,375	$1.494M	6.6%	$63.62	-96.8%	COM CL A	81578P106
XLO	XILIO THERAPEUTICS INC	667,742	$427K	1.9%	$17.03	-95.6%	COM	98422T100
—	RAPT THERAPEUTICS INC	12,437	$421K	1.8%	$19.75	—	COM NEW	75382E109
—	SUTRO BIOPHARMA INC	17,500	$202K	0.9%	$21.71	—	COM	869367102